Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-030973)

Filing Details

Accession Number:: 0001209191-17-030973
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-09 16:44:41
Reporting Period:: 2017-05-09

Filing Date:: 2017-05-09
Accepted Time:: 2017-05-09 16:44:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1689813	Biohaven Pharmaceutical Holding Co Ltd.	BHVN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1329505	Gregory Bailey	C/O Biohaven Pharmaceuticals, Inc. 234 Church Street New Haven CT 06510		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2017-05-09	1,076,299	$0.00	1,115,299	No	4	C	Direct
Common Shares	Acquisiton	2017-05-09	175,000	$17.00	1,290,299	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Series A Preferred Shares	Disposition	2017-05-09	1,076,299	$0.00	1,076,299	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Represents shares received upon conversion of Series A Preferred Shares.
Effective immediately prior to the closing of the Issuer's initial public offering of its common shares, each Series A Preferred Share automatically converted into one common share of the Issuer. The Series A Preferred Shares had no expiration date.